These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8695345)

  • 1. Current perspectives on camptothecins in cancer treatment.
    Dancey J; Eisenhauer EA
    Br J Cancer; 1996 Aug; 74(3):327-38. PubMed ID: 8695345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camptothecins: a review of their chemotherapeutic potential.
    Ulukan H; Swaan PW
    Drugs; 2002; 62(14):2039-57. PubMed ID: 12269849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
    Garcia-Carbonero R; Supko JG
    Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I inhibitors: topotecan and irenotecan.
    Creemers GJ; Lund B; Verweij J
    Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of topoisomerase I-targeting agents.
    Arbuck SG; Takimoto CH
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of the camptothecins.
    Takimoto CH; Wright J; Arbuck SG
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):107-19. PubMed ID: 9748525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors.
    Herben VM; Ten Bokkel Huinink WW; Schellens JH; Beijnen JH
    Pharm World Sci; 1998 Aug; 20(4):161-72. PubMed ID: 9762728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of camptothecin analogs in childhood cancers.
    Bomgaars L; Berg SL; Blaney SM
    Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology.
    Vassal G; Pondarré C; Boland I; Cappelli C; Santos A; Thomas C; Lucchi E; Imadalou K; Pein F; Morizet J; Gouyette A
    Biochimie; 1998 Mar; 80(3):271-80. PubMed ID: 9615866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials with the topoisomerase I inhibitors.
    Burris HA; Rothenberg ML; Kuhn JG; Von Hoff DD
    Semin Oncol; 1992 Dec; 19(6):663-9. PubMed ID: 1334279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.
    Gerrits CJ; de Jonge MJ; Schellens JH; Stoter G; Verweij J
    Br J Cancer; 1997; 76(7):952-62. PubMed ID: 9328159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camptothecins in clinical development.
    Zunino F; Pratesi G
    Expert Opin Investig Drugs; 2004 Mar; 13(3):269-84. PubMed ID: 15013945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of topoisomerase I inhibitors in anticancer treatment.
    Rodriguez-Galindo C; Radomski K; Stewart CF; Furman W; Santana VM; Houghton PJ
    Med Pediatr Oncol; 2000 Oct; 35(4):385-402. PubMed ID: 11025469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecins: a review of their development and schedules of administration.
    O'Leary J; Muggia FM
    Eur J Cancer; 1998 Sep; 34(10):1500-8. PubMed ID: 9893620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.
    Cho LC; Choy H
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):29-39. PubMed ID: 15255165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase I inhibitors: review and update.
    Rothenberg ML
    Ann Oncol; 1997 Sep; 8(9):837-55. PubMed ID: 9358934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The camptothecins.
    Pizzolato JF; Saltz LB
    Lancet; 2003 Jun; 361(9376):2235-42. PubMed ID: 12842380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The other camptothecins: recent advances with camptothecin analogues other than irinotecan and topotecan].
    Lavergne O; Bigg DC
    Bull Cancer; 1998 Dec; Spec No():51-8. PubMed ID: 9932086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase I inhibitors. An overview of the camptothecin analogs.
    Burris HA; Fields SM
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):333-55. PubMed ID: 8040144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase I inhibitors in the treatment of colorectal cancer.
    Rothenberg ML; Blanke CD
    Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.